Lilly Animal Health Division Makes Offer for J&J Animal Health Unit

Market News Video
March 14, 2011 AT 12:05 PM
Eli Lilly (LLY) said today its animal health division, Elanco, has made an irrevocable, unconditional offer to acquire the animal health business of Johnson & Johnsons (JNJ) Janssen Pharmaceutica. Janssen is based in Belgium, and its animal health business is primarily European-focused, targeting disease segments in companion animals and livestock, in particular swine and poultry.